← 홈

림프종

587개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 587개
CGTBiologicstaleMerck Sharp & Dohme LLCPhase 2

Stem cell infusion (Stem cell infusion)

Leukemia; Lymphoma · Leukemia

#Leukemia#CGT#Phase2#인기#세포유전치료+5
효능 ORR 90%임상시험 62상태 ACTIVE
CGTBiologicstaleYake Biotechnology Ltd.Phase 1

chimeric antigen receptor T cell treatment (chimeric antigen receptor T cell treatment)

T Cell Lymphoma; T-cell Leukemia · FRα

#FR#CGT#Phase1#인기#세포유전치료+5
효능 ORR 80.3%임상시험 62상태 ACTIVE
CGTBiologicstaleHebei Senlang Biotechnology Inc…Phase 2

Autologous CAR-T cells (Autologous CAR-T cells)

Leukemia; Lymphoma · FRα

#FR#CGT#Phase2#인기#세포유전치료+5
효능 ORR 80.3%임상시험 61상태 ACTIVE
ADCBiologicstaleEnyo PharmaPhase 2

B-CAP (B-CAP)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 0.04%임상시험 61상태 ACTIVE
ADCBiologicstaleNovumvedotin, nivolumab, doxorub…Phase 3

Bleomycin Sulfate (Bleomycin Sulfate)

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 · Lugano Classification Limited Stage Hodg

#LuganoClassificationLimitedStage#ADC#Phase3#인기#항체약물접합체+4
효능 ORR 96%임상시험 61상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCvedotin with dacarbazine or…Phase 2

DTIC (DTIC)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 96%임상시험 61상태 RECRUITING
ADCBiologicstaleRegeneron PharmaceuticalsPhase 3

Prednisone/ prednisolone (Prednisone/ prednisolone)

Follicular Lymphoma (FL) · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 95%임상시험 61상태 RECRUITING
ADCBiologicstalePfizerPhase 2

Sunitinib Malate (Sunitinib Malate)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 59%임상시험 61상태 RECRUITING
CGTBiologicSanofiPhase 2

gemcitabin (gemcitabin)

Extranodal NK/T-cell Lymphoma, Nasal Type · Extranodal NK/T-cell Lymphoma, Nasal Typ

#ExtranodalNKT-cellLymphomaNasalT#CGT#Phase2#인기#세포유전치료+5
효능 ORR 32%임상시험 61상태 ACTIVE
CGTBiologicstaleSinobioway Cell Therapy Co., Lt…Preclinical

CD19-targeted CAR-T cells (CD19-targeted CAR-T cells)

Lymphoma · CD19

#CD19#CGT#Preclinical#인기#세포유전치료+5
효능 ORR 94%임상시험 60상태 ACTIVE
CGTBiologicstaleBellicum PharmaceuticalssPhase 2

Chimeric antigen receptor (CAR, Chimeric antigen receptor, Chimeric antigen receptor (CAR) T-cell therapy)

Diffuse Large B Cell Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#CGT#Phase2#인기#세포유전치료+4
효능 ORR 80.3%임상시험 60상태 RECRUITING
ADCBiologicCzech Lymphoma Study GroupPhase 2

Prednisone tablet (Prednisone tablet)

Lymphoma, T-Cell, Peripheral · Lymphoma, T-Cell, Peripheral

#LymphomaT-CellPeripheral#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 85.5%임상시험 60상태 ACTIVE
ADCBiologicMylan Pharmaceuticals IncDM1A-mediated epigenetic si…Phase 1

Verapamil (Verapamil)

Recurrent Hodgkin Lymphoma; Refractory Hodgkin Lymphoma · FRα

#FR#ADC#Phase1#인기#항체약물접합체+5
임상시험 60상태 ACTIVE
CGTBiologicstaleAbbottvedotinPhase 2

Zidovudine (Zidovudine)

Lymphoproliferative Disorder; HHV-8 · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase2#인기#세포유전치료+5
임상시험 60상태 RECRUITING
CGTBiologicstaleAbClonvedotin-containing regimens…Phase 2

Anti-CD19 Chimeric Antigen Receptor T cell (AT101, AT101(Anti-CD19 Chimeric Antigen Receptor T cell))

B-cell Non Hodgkin Lymphoma · CD19

#CD19#CGT#Phase2#인기#세포유전치료+5
효능 ORR 38%임상시험 59상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCsPhase 2

Hyaluronidase (Hyaluronidase)

Diffuse Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 64.3%임상시험 59상태 DISCONTINUED
ADCBiologicNanogen Pharmaceutical Biotechn…Phase 2

Neulasta (Neulasta)

Hodgkin Lymphoma; Anaplastic Large Cell Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 64%임상시험 59상태 ACTIVE
ADCBiologicstaleGenzyme, a Sanofi Companyvedotin-based regimens in C…Phase 2

Reduced Intensity Conditioning (Reduced Intensity Conditioning)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 2%임상시험 59상태 ACTIVE
CGTBiologicstalePaolo Caimi, MDPhase 1

Allogeneic NK cells (Allogeneic NK cells)

Non Hodgkin Lymphoma; B-cell Non Hodgkin Lymphoma · Non Hodgkin Lymphoma

#NonHodgkinLymphoma#CGT#Phase1#인기#세포유전치료+4
효능 ORR 5%임상시험 58상태 RECRUITING
AntibodystaleNovartisApproved

Basiliximab (Basiliximab)

Type 1 Diabetes Mellitus · Extranodal NK/T-cell Lymphoma

#ExtranodalNKT-cellLymphoma#Antibody#Approved#인기#항체+4
효능 ORR 10%임상시험 58상태 ACTIVE

3 / 30 페이지

← 이전다음 →